Current and future research efforts in oligometastatic non-small cell lung cancer—a systematic review

BACKGROUND: Major progresses in the systemic treatment of non-small cell lung cancer (NSCLC) were obtained during the last decade, including the use of immunotherapy and tyrosine kinase inhibitors (TKIs), with impressive results in terms of response and survival rates. Moreover, novel imaging and ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Brandão, Mariana, Durieux, Valérie, Berghmans, Thierry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Review Article on Oligometastatic NSCLC: Definition and Treatment Opportunities
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350078/
https://www.ncbi.nlm.nih.gov/pubmed/34430381
http://dx.doi.org/10.21037/tlcr-20-964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350078/
https://www.ncbi.nlm.nih.gov/pubmed/34430381
http://dx.doi.org/10.21037/tlcr-20-964

Ejemplares similares